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Abstract 
We examined the HPV vaccination process in adolescent Japanese girls, including protective and 
obstructive factors to develop and practice enlightenment activities and educational interventions for 
promoting HPV vaccination to adolescent Japanese girls and their families. We conducted 
semi-structured interview with 20 adolescent Japanese girls who lived in the wider Tokyo area, 
Japan. To analyze the interview data, we adopted the modified grounded theory approach. We 
identified three stages in the vaccination process: first encounter with cervical cancer and HPV 
vaccine, thoughts about vaccination, and adjustment with parents toward vaccination. The girls 
“knew” their knowledge and information on cervical cancer and the HPV vaccine from experts, 
parents, and friends, “considered and discussed” HPV vaccination in their own way or with parents, 
and “arranged” actual vaccination. This process was influenced by the promoting/obstructive factors 
in each stage. Health care providers should understand the experiences and feelings of adolescent 
girls who were confronted with HPV vaccination in the context of their vaccination process and 
conduct enlightenment activities to promote vaccination, keeping the promoting and obstructive 
factors suggested in this study in mind. 
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INTRODUCTION 
Annually, 8474 persons are affected by cervical cancer (CC) in Japan, and 2519 persons die of the 
disease per year (Health, Labour & Welfare Ministry, 2011). The age-related structure shows an 
increase in morbidity at 20-24 years of age and rises rapidly after 25 years until peaking at around 40 
(Health, Labour & Welfare Ministry, 2011). CC is the primary cause of morbidity in women in their 
20s to 30s (Study Group to Protect a Woman from Cervical Cancer, 2008). It is not only life 
threatening, but can deprive women of the possibility of pregnancy and childbirth, and inflicts much 
pain and suffering on young women, physically and psychologically.  
CC is caused by human papilloma virus (HPV) (Walboomers et al., 1999). To prevent infection 
with HPV in women, HPV vaccine has recently been developed (Lehtinen et al., 1996). Bivalent 
vaccine (Cervarix®) and quadrivalent vaccine (Gardasil®) have been approved and are available in 
96 and 123 countries, respectively (Garland et al., 2007; Paavonen et al., 2009). In Japan, marketing 
approval was given to Cervarix in 2009 and Gardasil in 2011, and these vaccines have been available 
since 2010 and 2011, respectively.  
The official HPV vaccination rate is not released on a national level because public funding 
programs for vaccination are administered by local governments in Japan. However, there are some 
reports on vaccination rates compiled by local governments that focus on mass vaccination (Hayashi 
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et al., 2012; Kobayashi et al., 2012). Compared with routine vaccination, the vaccination rate of 
optional vaccines is clearly low. To determine the introduction of the HPV vaccine in Japan, health 
economic modeling was used to analyze the aspect of vaccination cost. In November 2010, the 
Ministry of Health, Labour and Welfare issued the “Notification on the implementation of urgent 
vaccination program of CC etc.” Following the notification, public financial support was expanded 
in local governments across Japan in 2012. In this program, the national and local governments bore 
half of the vaccination cost for girls of 13 to 16 years old until the end of March 2012. Later, the 
extension of public funding program was decided by the cabinet up to the end of March 2013. The 
HPV vaccination rate, however, did not increase. Actually, the HPV vaccination rate in young 
women of age out of public financial support was only 5.4%, according to a local government report 
(Miyagi, 2011).  
 
LITERATURE REVIEW 
The number of survey reports about HPV vaccination has recently been increasing, and they 
mainly demonstrated; a) impact by HPV vaccines introduction; b) factors related to HPV vaccination 
rates in adolescent girls; c) discussions regarding HPV vaccination between parents and their 
daughters; and d) the association between HPV vaccination and girls’ sexual behavior. 
a) Impact of HPV vaccines introduction 
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Tabrizi et al. (2012) and Markowitz et al. (2013) reported the reduction in human 
papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in each 
country. In Australia, Ali et al. (2013) showed that the significant declines in the proportion of 
young women and heterosexual men having genital warts five years into national HPV program 
from national surveillance data and Brotherton et al. (2013) reported the decrease in incidence of 
high-grade cervical abnormalities within 3 years after the implementation of a population-wide HPV 
vaccination program. Declining rates of high-grade cervical lesions in young women due to HPV 
vaccines was also reported in the United States by Niccolai et al. (2013). 
 
b) Factors related to HPV vaccination rates.  
Hughes et al. (2009) reported women and wealthy families are more likely to collect 
information about HPV vaccinations from Internet or advertisements and have more knowledge 
about HPV vaccinations than men and the needy families. Their study also showed parents who had 
more knowledge of HPV and HPV vaccine were more likely to have their daughters vaccinated 
against HPV than parents who had less knowledge. Additionally, McRee et al. (2012, a) reported 
having learned about HPV vaccine via the Internet was associated with parents’ higher knowledge, 
positive perceptions of HPV vaccine, and HPV vaccination willingness.  Marchand et al. (2012) 
showed that sharing vaccination experience of vaccinated women with unvaccinated women was one 
of the factors that improved awareness of HPV vaccination in a survey of female college students. 
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They also described that learning about HPV in health- related major in college or having family 
members who have health-related work were significantly associated with the acceptance of the 
HPV vaccine. Overall, it has been shown that the higher levels of awareness and parents’ and their 
daughters’ knowledge of HPV and HPV vaccination lead to higher HPV vaccination rates.  
On the other hand, according to Darden et al. (2013), the most frequent reasons why some 
adolescents will not receive vaccination against HPV were reported that “Not recommended”, “Not 
needed or not necessary”, “Not sexually active”, and “Safety concerns/Side effects”. It has been also 
shown that the most common reason why parents and their daughters refused HPV vaccination was 
uncertainty about vaccine safety or concern about potential adverse events (Kester et al., 2012; 
Sotiriadis et al., 2012). Relating to this, Zimet et al. (2013) stated that most fears related to HPV 
vaccine are more related to myth than reality and HPV vaccines are quite safe, and they can no 
longer be considered “new”. Teitelman et al. (2011) reported that beliefs that their health insurance 
does not cover the HPV vaccine, a long wait to get an appointment, and limited availability of 
appointments are the barriers to vaccination for some women. Chou et al. (2011) reported that the 
combination of younger age and practice location was strongly associated with completion rates: 
11-17 years-old-girls or patients who initiated vaccination at urban practice locations were 
associated with very low likelihood of completing HPV vaccination. Liddon et al. (2013) 
investigated the parental underestimation of child’s sexual debut and suggested waiting until a parent 
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thinks a child is sexually active could result in missed opportunities for prevention and implications 
for HPV Vaccine Uptake at age 11 or 12 years. 
 
c) Discussion about HPV vaccination between parents and their daughters.  
Colgrove et al. (2010) argued that vaccines against sexual transmitted infections (STI) might 
threaten teenage abstinence, and that having discussions on STI with girls 11 or 12 years of age was 
difficult in their study. Thus, they are taking a cautious stance toward HPV vaccine for teenagers. On 
the other hand, McRee et al. (2010,b) concluded that discussions about sex between mothers and 
11-14 year-old daughters who are in the ages most likely to be influenced by sexual activities is 
meaningful and that HPV vaccination discussions provide opportunities for promoting 
mother-daughter communication about sex.  
d) The association between HPV vaccination and girls’ sexual behavior.  
Bednarczyk et al. (2012) showed that HPV vaccination in the recommended ages was not 
associated with increased sexual activity–related outcome rates in adolescent girls in a cohort study. 
Liddon et al. (2012) highlighted disparities in HPV vaccine initiation by insurance status among 
girls/women aged 15-24 years and by race/ethnicity among women aged >19 years and showed that 
no association was found between HPV vaccination and risky sexual behavior. 
Thus, previous studies have reported promoting or inhibitory factors and the discussion about 
HPV vaccination between parents and their daughters. However, there is no study that clarified the 
 
 
9 
 
process of girls’ HPV initiation including the way how parents and girls collected information about 
HPV vaccine and how they made decisions. It is assumed that the further elucidation and 
consideration of the process for girls being vaccinated against HPV may be very useful to review the 
intervention time, locations, and measures for vaccination promotion in clinical practice.    
 
STUDY AIM 
The aim of the study was to examine the process of Japanese adolescent girls to receive HPV 
vaccine and factors influencing these decisions and implementations. The findings of this study are 
very important for healthcare providers to develop and practice enlightenment activities and 
educational interventions for promoting HPV vaccination to adolescent Japanese girls and their 
families.  
 
METHODS 
Study design 
We conducted a qualitative study by using the modified grounded theory approach (M-GTA) 
(Kinoshita, 2003). As part of the study, we interviewed participants inductively, and analyzed their 
narratives. 
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Participants 
The participants were recruited from three pediatric clinics in the Tokyo metropolitan area. The 
interviewers did not engage in the professional health-care practices in these clinics.  
The criteria for inclusion in the study were as follows : (a) girls who are 10 to 19 years and 
received at least one HPV vaccination that was started in December 2009, or (b) girls who are 10 to 
19 years and knew about the HPV vaccine, but decided not to undergo vaccination; (i) living with 
family in the community; (ii) assessed their mental and intellectual status by pediatricians to 
determine their fitness for participation in the study; (iii) able to give informed consent; and (iv) able 
to participate in an interview in Japanese. 
For recruitment purposes, we asked the physicians to recruit those adolescent girls whom the 
physician believed had met the inclusion criteria. If adolescent girls were interested in the study, the 
interviewers had permission to contact their caregivers and them by telephone. A meeting was then 
held with the potential participants, and they were provided with information about the study and on 
ethical issues. Twenty-one adolescent girls agreed to participate in this study. A girl was excluded 
from the study due to failure to set the schedule. 
 
Data collection 
We used theoretical sampling to recruit the participants (Glaser & Strauss, 1967). In theoretical 
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sampling, the participants who are likely to provide data similar to or in contrast to the existing data 
are sampled. For example, with the physicians’ help, we recruited adolescent girls who received 
HPV vaccination by their private expense without government support after collecting a certain 
amount of data on the adolescent girls who received HPV vaccination with government support.  
We contacted 21 adolescent girls, 20 of whom agreed to participate in the study. The data were 
collected in the period of 2011summer–2012spring, using narrative interviews (Oda et al., 2002). 
Each of the 20 participants was interviewed once. We prepared an interview guide so that the 
interviews would be conducted along the purpose. To ensure the quality of the guide, we discussed it 
with specialists who were engaged directly in providing professional health-care practices to 
children and their families. During the interviews, participants were asked about the factors they 
considered in making their decision about HPV vaccination, difficulties associated with the 
decision-making process, and the reasons why they decided in favor of or against getting the HPV 
vaccine. Participants who did not get vaccinated for HPV were asked if they would consider the 
possibility of the vaccination in the future. Additional information such as demographic data and 
other vaccination history was collected from their parents. The framework of the interview 
comprised two dimensions: 
1. Level of knowledge on CC and the HPV vaccine 
1) When and how did you find out about the HPV vaccine? 
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2) Do you know the purpose of HPV vaccination? 
i) Do you know what it is for?  ii) When and how did you find out about it?  
3) (Questionnaire) Read A) to G) texts below and choose Correct, Wrong, or Unknown.  
A) CC is mainly caused by infection with HPV (human papilloma virus)  
B) HPV infection is transmitted primarily by sexual intercourse 
C) About 80% of adult women have been infected with HPV at least once 
D) CC is increasing in women in their 20s and 30s in Japan 
E) HPV vaccine can prevent about 60% of CC 
F) CC can be cured 100% and does not affect pregnancy or delivery if detected early 
G) Even if you receive HPV vaccination, you have to undergo CC screening 
2. Expression of attitudes and behaviors  
1) Did you want to have HPV vaccination? Why or Why not? 
2) What do you think about the HPV vaccine being available in Japan for cancer prevention?  
3) Is HPV vaccination necessary for you? Why or Why not? 
4) Were you anxious about or afraid of having HPV vaccination? Describe specifically.  
(For those vaccinated) What did you feel when you were vaccinated? 
5) Before you received HPV vaccination, did you talk about it with your family or friends? What 
did you talk about? 
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6) What was the attitude of your family and friends regarding HPV vaccination? 
We posed open-ended questions (except questions about CC and the HPV vaccine). The 
answers to the questions were checked after the interview. When the subject of vaccination expense 
came up in conversation during the interview, the interviewer asked about participants’ preferred 
amount of self-pay and public financial support.  
The interviews were conducted in a private room at institutions. The mean duration of the 
interviews was 45 min (the time ranged from 39 to 66 min). With the participants’ permission, 
interviews were tape-recorded and transcribed verbatim by the principal author.  
 
Data analysis 
To analyze the data, we used the Modified Grounded Theory Approach (M-GTA) (Kinoshita, 
2003), which was developed on the basis of methodology that was formulated by Glaser and Strauss 
(1967) on the GTA. When using the M-GTA, data analysis is conducted in several stages. Initially, 
the transcript of one of the participants is read a number of times, with the focus of attention being 
the theme of the study. Then, as the result of interpretive analysis, concepts are created. Unlike the 
GTA, the concept in the M-GTA is the minimum analytical unit, and each concept is derived from 
several pieces of data. When a concept is being created, data that are similar or antithetical to the 
concept also are examined in order to pre-empt an arbitrary interpretation by the analyst. Several 
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concepts are created, and the relationships among them are determined. Then, the concepts are 
categorized. Finally, the phenomenon being studied is explained by using the categories and 
concepts that have been developed. In this study, data collection and data analysis were reiterated 
until theoretical saturation was reached. 
We analyzed the verbatim data in Japanese. All of the categories, concepts, and quotations that 
were provided by the participants’ narratives, which appear in this article, were also originally in 
Japanese. We translated these into English (they were edited and proofread by a professional) so that 
they could be read by international researchers. To ensure the accuracy and validity of the data 
analysis, the principal author analyzed the data under constant discussion with other authors. 
Furthermore, we sent the results to two participants for member-checking. Their feedback indicated 
that the categories that were developed by the authors adequately reflected the experiences of the 
two participants. 
 
Ethical considerations 
We received approval for the study through the ethics committee of the Society of Ambulatory 
and General Pediatrics of Japan. We informed each participant and her mother, both verbally and in 
writing, about the purpose of the study and assured the participants that their information would be 
treated confidentially. We also informed them that their participation in the study was voluntary and 
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that refusal to participate would not disadvantage of the clinical services they receive. We received 
not only parents’ but their daughters’ permission to conduct interview with those younger than 20 
years of age. 
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RESULTS 
We interviewed 20 vaccinated/unvaccinated adolescent girls of school age between 12-17 years 
old who attended to high school or junior high school and lived in the wider Tokyo area, Japan. The 
characteristics of the study participants are shown in Table 1. The mean age of the girls was 14.9 
years (standard deviation, SD: 1.5, range: 12-17). The mean age of the mothers was 45.1 years (SD: 
5.5, range: 36-57). Eight girls completed all three HPV vaccinations. Another eight girls completed 
the first or second vaccination with at least one injection left undone. Four girls had no vaccination 
including pendency. 
We identified three stages in the HPV vaccination process for adolescent Japanese girls of 
school age: i)First encounter with CC and HPV vaccine, ii) Think about and make decision to get 
HPV vaccine, iii) Adjustment with parents toward actual vaccination (Fig. 1). Each category and 
concept is described in detail below. 
 
i) First encounter with CC and HPV vaccine 
This category consisted of two concepts: [Collect knowledge and information on CC and the 
HPV vaccine] and [Know experience of vaccinated friends and vaccination state of peers]. This is 
the stage when girls know CC and the HPV vaccine for the first time and see the vaccination state of 
their surroundings. 
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As factors relevant to the HPV vaccination process, amount and quality of knowledge and 
information on CC and the HPV vaccine given to the adolescent, adolescent’s health literacy, and 
peer pressure were extracted on this concepts.  
 
 [Collect knowledge and information on CC and the HPV vaccine] 
Most of the participants had acquired knowledge and information on CC and the HPV vaccine 
through school-sponsored briefings on vaccine with experts or conversation with local health care 
providers, parents, and friends. Primary information tools included posters, leaflets, television ads, 
and the Internet. For example: 
I heard about the vaccine with my mother by chance when I went to see a doctor for a cold 
because I met the qualifying age for the vaccine. 
 
I happened to see a commercial for this vaccine on TV. Mother said to me, “See, this is a 
new vaccine to prevent cervical cancer.” I thought “this is amazing, it prevents cancer”. 
So I searched it straight away on the Internet.  
 
 [Know experience of vaccinated friends and vaccination state of peers] 
If a participant had friends who had already been vaccinated, she would have heard about their 
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vaccination experience from them and gained some insight. Participants also knew about the 
vaccination state of others regarding how far the HPV vaccine was prevalent around them. 
Adolescent girls who found the vaccination rate to be high in her immediate circle spoke of peer 
pressure from friends who had been vaccinated. For example: 
About half the girls have already had all three-times injections of HPV vaccine in my 
class. Including those on the way to completion, about 2/3 are receiving injection now.  
 
My friend, who had a vaccination, says “Haven’t you had a shot yet?” or “Are you 
thinking of your future?” So I became a little impatient.  
 
ii) Think about and make decision to get HPV vaccine 
This was core category. The core category is consisted of two categories: <First thoughts and 
wavering in attitude toward HPV vaccination> and <Discussion with parents>. In this stage, 
participants who had obtained knowledge and information on CC, HPV vaccine, and surrounding in 
the former stage considered HPV vaccination in their own way and discussed the matter with parents. 
In the case of a physically immature girl whose menstruation had not yet started, the girl and her 
parents recognized the value of vaccination, but decided not to receive it at that moment.  
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<First thoughts and wavering in attitude toward HPV vaccination> 
This category consisted of five concepts: [Fear and desire to escape from CC], [Recognition the 
value and admiration for HPV vaccine], [Priority of qualifying for public financial support], 
[Anxiety regarding IM injection], and [Distrust of the HPV vaccine]. Many participants recognized 
CC as a scary disease specific to women, and valued the HPV vaccine as a great new vaccine with a 
potential prophylactic effect against the disease. In cases of the recipient of public aid, participants 
felt that the priority was to obtain public support because the HPV vaccine is expensive. On the other 
hand, some participants were nervous regarding receiving an intramuscular (IM) injection, and 
others were wary of receiving a vaccination easily due to the novelty because this vaccine was 
recently admitted in Japan. The latter participants were wavering in their attitude between desire and 
fear of the vaccination.  
In this category, relevant to HPV vaccination process, protective factors extracted from the data 
were fear of CC, possibility of developing CC, awareness of preventing CC, future visions and ideal 
self-image, public financial support system. On the other hand, obstructive factors extracted from the 
data were financial burden (if the participants is out of age bracket to qualify for public financial 
support), and voluntary nature of vaccination.  
 
[Fear and desire to escape from CC] 
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Three out of 20 subjects knew that the main cause (transmission route) of CC was sexual 
intercourse, and 5 out of 20 subjects knew that about 80% of adult women could be infected with 
HPV at least once in their life (infection rate). Additional participants had been imagining that girls 
and women with CC would have poor prognosis.  
Participants who had a clear vision of lifestyle as a woman or specific future self-image were 
more likely to fear CC and have a strong desire to avoid CC. For example: 
I know I may lose my womb in the worst case if I get cervical cancer. I want to avoid it at 
any cost. I want to have a baby in the future. So, I think it is better to take an injection, 
even though it is burdensome now.  
 
[Recognition the value and admiration for HPV vaccine] 
Eighty percent of participants knew that CC could be prevented by the vaccine, but most of 
them overestimated the prevention rate to be 80 to 100%, which has been estimated to be 
approximately 70% by Onuki (2009). Participants acknowledged the high value and praised the HPV 
vaccine in view of CC prevention. For example: 
I guessed there has never been such a vaccine to prevent cancer before, so I thought HPV 
vaccine was an amazing vaccine. I recognize it a high-value vaccine especially for women 
who really want to have children in the future, like me.  
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[Priority of qualifying for public financial support] 
Qualification for public financial support encouraged vaccination in 11 out of 16 participants 
who were already being vaccinated. For example: 
My friends and mother said to me, “This vaccine is really expensive at the original price, 
but you can receive it for free now.” I felt lucky to hear that. 
 
[Anxiety regarding IM injection] 
Some participants heard the word “intramuscular injection” for the first time. Participants with 
a higher awareness of their low tolerance for pain felt greater anxiety for IM injection. For example: 
I heard from a friend that she received the vaccine, and it was different from an ordinary 
injection and really painful because it was inserted into muscle. I am very sensitive to pain, 
so I was afraid that I would not be able to stand it.  
 
[Distrust of the HPV vaccine] 
Some participants expressed distrust and concerns for the effect, side effects, and adverse 
events caused by the HPV vaccine that has only recently been approved for use in Japan. For 
example: 
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It will take a long time to know the effect of this vaccine. I do not want to faint or die, at 
worst, as a result of the injection.  
 
<Discussion with parents> 
This category consisted of three concepts: [Tell own thoughts on HPV vaccination to parents], 
[Share and discuss the knowledge and information on CC and the HPV vaccine with parents], and 
[Prioritizing parents’ thinking on HPV vaccination]. 
As factors related to this stage, daily parent-daughter relationship/amount of conversation, 
vaccine-related health literacy of parents, parental attitude to health, adolescents’ reliance on parents, 
and parental influence on the adolescent were extracted.  
 
[Tell own thoughts on HPV vaccination to parents] 
In their discussion with the parents, subjects had communicated different ideas as to whether or 
not they wanted to have the vaccination, or they wanted to postpone the vaccination. This 
communication generated discussion between the parents and the adolescent. For example: 
The night of the day on which I had received the explanation at school, I told my mother 
and father “I heard about an injection called the HPV vaccine. I want to get it.” My father 
already knew about the vaccine, and told me “Wait until the local government sends us a 
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notice of financial support.” 
 
Then it came to, “So what are we going to do with the injection?” when I was chatting 
with my mother. I said, “I don’t want to have the injection yet,” because I have not started 
my periods. Mother said to me, “O.K. You can receive the injections after you enter high 
school. We can afford it.”  
 
[Share and discuss the knowledge and information on CC and the HPV vaccine with parents] 
Participants communicated the knowledge and information on CC and the HPV vaccine that 
were provided from the outside to their parents in the discussion. Some adolescent girls reported that 
more detailed knowledge and information were given by their parents, and parent-daughter 
discussion was progressed. For example: 
My mother told me how cervical cancer could infect me, saying this was a good chance for 
me to know. I heard the main infection route was sexual intercourse. So I thought it too 
early for me to get a shot. But, after talking with my mother, finally we decided to have 
them done now because I will need the vaccine in the future anyway.  
 
[Prioritizing parents’ thinking on HPV vaccination] 
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In 5 out of 16 participants who were already being vaccinated, the parents advised the daughter 
to have the vaccination. Finally, after discussion, the daughter gave priority to the parents’ thinking 
and agreed on vaccination. Also in the other 11 participants already vaccinated, the parents’ thinking 
took primacy over that of the daughter when they decided on the timing of vaccination and other 
schedules. This tendency was more notable in participants with higher “reliance on the parents” and 
“susceptibility to the parents’ influence” For example: 
In fact, I did not want to get a shot, but I decided to have it, because my mother and father 
said I should have the injections while I have the chance. I thought that they told me so 
because they cared about me.  
 
iii) Adjustment with parents toward actual vaccination  
This category consisted of two concepts: [Arrange the vaccination period and schedule with 
parents] and [Parents make an appointment with hospital]. In this stage, the parents and adolescent 
girl who have had a positive discussion for vaccination started to make specific plans and act 
toward receiving the HPV vaccination.   
As factors relevant to this stage, schedule adjustment between the parents and adolescents and 
parents’ ability to search local resources were extracted from the data. The obstructive factor 
extracted from the data was frequent vaccination against busyness of the parents and adolescents or 
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lack of time.  
 
[Arrange the vaccination period and schedule with parents] 
Participants and their parents who wished to have the vaccination had discussed when to start 
the three doses of vaccination. Taking account their schedules in the near future, the daughters told 
their parents when they could receive vaccinations without conflicting with preparatory schools or 
club activities. The parents also discussed their preferred schedules and adjusted the vaccination 
timeline with each other. Many adolescent girls told of instances when girls were asked to wait for a 
vaccination or urged to take vaccination by the parents to coordinate with age/periodic limitation of 
public financial support because HPV vaccination of 13 to 16 years-old-girls had been supported for 
public money in Japan. Some families were unable to have a daughter start the vaccination due to 
failure to adjust their schedule, though the parents and girls both wished to have the vaccination. For 
example: 
Parents told me “you should do it while the subsidy is provided if you are going to have 
the injection.” So I said, “Then I will go to get the first shot next week. Test week is going 
to begin with the week after that.”  
 
[Parents make an appointment with the hospital] 
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When the parents and adolescent girls were able to adjust the vaccination period and schedule, 
the parents then looked for hospitals provided the HPV vaccination service. In all vaccinated cases, 
parents made an appointment for vaccination and accompanied their daughter on the hospital visit. 
For example: 
Honestly, I did not want to go to the obstetrics and gynecology hospital to have an 
injection. So mother looked for another pediatric clinic. She makes the appointment every 
time. When the time for the injection was coming up, she reminded me, saying “Next 
injection is XX. Don’t forget.”  
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DISCUSSION 
This study found that subjects “encountered” the knowledge and information on CC and the 
HPV vaccine through experts/parents/friends, “thought about” HPV vaccination in their own way or 
with parents, and then “arranged” the vaccination. This process was influenced by the following 
extracted factors in each stage: the amount and quality of knowledge and information on CC and the 
HPV vaccine; child’s health literacy on CC and the HPV vaccine; peer-pressure; fear of CC; 
possibility of developing CC; awareness of preventing CC ; future self-image and visions; public 
financial support system; parent-child relationship; parental health literacy; parent-child 
conversation; parental attitude to health; child’s reliance on parents; parental influence; schedule 
adjustment between parents and child; and parental ability of resource search. As obstructive factors 
of the process, the following were extracted from the data: financial burden on family with children 
out of the qualifying age bracket; voluntary nature of vaccination; and difficulty adjusting the 
vaccination schedule due to the busyness of the child. These include factors previously suggested by 
the relevant literature (Chou et al., 2011; Hughes et al., 2009; Kester et al., 2012; McRee et al., 2012, 
a; Marchand et al., 2012; Sotiriadis et al., 2012; Teitelman et al., 2011) and those revealed by the 
present study for the first time. This study appears to be the first account of the process how 
adolescent girls arrive at HPV vaccination in Japan. 
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Stage 1: First encounter with CC and HPV vaccine 
The adolescents participated in this study told that she felt a significant impact when they knew 
about the existence of the HPV vaccine with the potential to prevent cancer. The impact also seems 
to have been significant for parents. None of the children failed to be informed of “cancer-prevention 
vaccine” if they were encouraged to have vaccination by parents. As suggested by Hughes et al. 
(2009) and Hamlish et al. (2012), the quality of the explanation of the HPV vaccine provided by 
parents and healthcare providers can have a significant influence on the child’s vaccination. The fact 
that all participants recognized the HPV vaccine as a “cancer-prevention vaccine” in this study bore 
out the notion that at least minimum knowledge on the vaccine was transmitted. Kang and 
Moneyham (2011) reported that adolescent girls were more willing to receive the HPV vaccination if 
it was recommended by parents or healthcare providers than by friends or teachers. And Huges et al. 
(2011) suggested that the programs to improve HPV vaccine delivery in primary care should focus 
on promoting effective parent-clinician communication. So it will be essential to focus on the 
education of health care professionals regarding indications for HPV vaccination and approaches to 
communicating most effectively with adolescent and parents about the safety and benefits of 
vaccination and the risks associated with non-vaccination. 
In Japan, HPV vaccination of 13 to 16 years-old-girls is supported for public money, based on 
the national immunization schedule. Meanwhile, some participants were not informed of the 
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recommended age for the HPV vaccination, public financial support system, and the specific method 
of vaccination (including pain associated with IM injection and the requirement of three IM 
injections at intervals). One participant who was in the third year of junior high school and did not 
know the recommended age said that it was too early for her to be vaccinated. Another participant 
who received the first vaccination without knowing the specific method of vaccination said that she 
was shocked by the severe pain of the IM injection and scared of the second and subsequent 
vaccinations. Another participant said that she, who had thought it would finish in one shot, and lost 
her motivation at the thought of having to have another two injections. The girls should be informed 
of the recommended age for HPV vaccination as well as the transmission route of CC. It was found 
only 3 of 20 subjects knew that HPV, the most common cause of the CC, can be sexually transmitted. 
Some participants misunderstood that CC would develop spontaneously like other kinds of cancer. 
The specific method of vaccination must be well communicated beforehand to avoid medical trauma 
or injection trauma in adolescents. Similar to the findings of Kessels et al. (2012), the availability of 
public funding often prompted participants in this study to have vaccination in most cases. The 
findings highlighted that full dissemination of financial support information would be required at 
Stage 1 in addition to vaccine information. 
The health literacy of the adolescent daughters and parents is also important in Stage 1. Health 
literacy in this context means personal ability to search, acquire, understand, and make use of 
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information required to make a decision on HPV vaccination. Naturally, adolescents are required to 
gain health literacy as the receivers of the vaccine, but the levels of parental literacy were thought to 
be various and it actually reflected both the contents and the quality of the explanation from parent 
to adolescent in this study. 
Consistent with the discussion on peer-pressure in a study by Marchand et al. (2012), many 
adolescents in this study were interested in the HPV vaccination state of their peers. Since the HPV 
vaccine has just been released in Japan, participants were curious about their peers’ experience of the 
HPV vaccination to a clear picture of the vaccination (i.e., modeling). And the participants who got a 
number of peer reports of syncope due to IM injection had higher levels of anxiety regarding the 
vaccination. 
 
Stage 2: Think about and make decision to get HPV vaccine 
Many adolescents were conflicted about between desire to avoid CC and anxiety regarding 
HPV vaccination. Their recognition of a “cancer-prevention vaccine” was so strong and their 
“admiration” for the development of the HPV vaccine was evident. Adolescents who made a 
realistic estimation of morbidity with clear future visions, intense fear of CC, and higher awareness 
of prevention were more likely to think about the HPV vaccination in a positive manner. Previous 
studies have suggested that health awareness and knowledge of vaccine would influence the 
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consideration of vaccination in adolescents (Kessels et al., 2012; Marchand et al., 2012). As Kassels 
et al. (2012) indicated, professionals are required to accurately inform adolescents of the pathology, 
prognosis, transmission route of CC, and prevention effects after vaccination. 
While the study found that the public financial support system was a positive factor in 
considering vaccination in 13 to 16 years-old-girls as described in Stage 1, some adolescent girls 
unqualified for public funding said that the expensive cost of HPV vaccination had been actually an 
obstacle to vaccination for them and their family. Since Kassels et al. (2012) have shown that health 
insurance coverage of vaccination is a factor that promotes vaccination, the Japanese government is 
expected to continue the financial support system and broaden the age qualification bracket for 
funding as a policy. 
According to Darden et al. (2013), as the most frequent reasons for not vaccinating adolescents, 
“Safety concerns/Side effects” were reported recently. In our study, anxiety regarding the HPV 
vaccination was largely divided into worry about the IM injection and distrust of the vaccine itself. 
Participants said that worry about the vaccination mainly consisted of pain associated with IM 
injections, distrust of the vaccine consisted of syncope reports, and uncertainty of the effect. The 
worries and doubts were described by mothers in a study by Kester et al. (2012); however, we heard 
these statements from the children themselves in this study, probably due to much conversation 
between Japanese parents and their children as described below. Health care providers should 
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exercise their ingenuity in the IM injection technique to reduce pain and provide the adolescent and 
family with accurate information on the adverse events and vaccine effect. 
Adolescent girls were able to share information on the HPV vaccination with parents and 
discuss what they thought in conversation with parents. Consequently, exchange of knowledge and 
information and bilateral improvement in health literacy occurred in the case of parents and 
adolescents (mothers and daughters, in particular) who had a good relationship and a lot of 
conversation every day. In case of parents and adolescents with a much better relationship, the topic 
naturally shifted to the daughters’ future and childbearing as they were talking about CC, or 
woman-specific malignancy, and they seemed to have a positive discussion regarding HPV 
vaccination. Of two participants whose periods had not yet started, one immediately decided to have 
vaccinations with the help of the financial support system, and the other decided to have 
vaccinations when her periods started, both after full discussion between the respective parents and 
their adolescent daughters. As mentioned here, discussion between parents and their daughters was 
essential in deciding whether or not to receive the HPV vaccination and to discuss the time of 
vaccination. Considering that parent- daughter discussion was absent or poor in three of four 
unvaccinated cases, the maturity levels of parent-daughter discussion could be one of the most 
crucial factor for promoting HPV vaccination in adolescent girls. 
In this study, daughters with a high degree of reliance and susceptibility to their parents tended 
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to follow their parents’ thinking on vaccination. As suggested by Hughes et al.(2009) and Hamlish et 
al.(2012), the amount of knowledge and information and literacy level in parents would be reflected 
in the quality of explanation to children, and furthermore, the vaccination rate. Mullins et al.(2013) 
also stated that HPV vaccine efficacy and safety are important topics to discuss with both girls and 
mothers; educating mothers is important for health care professionals because parents are a preferred 
source of vaccine-related information for girls. To achieve high rates of HPV vaccination in Japan, it 
will be essential to focus on the education of health care professionals regarding indications for HPV 
vaccination and approaches to communicating most effectively with adolescent and parents about 
the safety and benefits of vaccination and the risks associated with non-vaccination. We propose 
holding “school briefings” to provide adolescents and parents with the opportunity to hear and think 
about the knowledge and information on CC and the HPV vaccine together. It is also preferable if 
information on public financial support is provided from local government staff on site.  
 
Stage 3: Adjustment with parents toward actual vaccination  
Following the discussion in Stage 2, parents, especially mothers, played an important role in 
having their daughters receive the HPV vaccine. Parents discussed with their daughters who were 
busy with club activities or at cram school to find suitable times for vaccination, planned the 
vaccination with the schedule in mind, located the hospital, made appointments, and took their 
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daughters to the hospital. The ability to make arrangements and the efforts of parents are essential 
for adolescent Japanese girls to achieve HPV vaccination. Unless parents (guardians) cooperate and 
play a role, the HPV vaccination process in adolescent girls would never be complete. Health care 
providers should understand this and focus on enlightening activities on vaccination so that parents 
(guardians) voluntarily assume the responsibility.  
At the same time, interventions are needed to encourage parents to make arrangements and take 
actions. Teitelman et al. (2011) suggested that “inconvenience of making appointments” and 
“limitation of hours open for appointments” could be a barrier to vaccination. For the same reasons, 
it took a lot of time to achieve vaccination in some cases in this study. Junior high and high school 
students living in urban areas of Japan are always busy going to cram school and other lessons every 
day, even during weekdays. For example, proposing a model vaccination schedule (the first and 
second injections in summer vacation and the third in winter, etc.) could be one intervention for such 
busy students. It is also preferable to give parents a list of local medical institutions (pediatrics and 
internal medicine) providing an HPV vaccination service to save their time and effort searching for a 
hospital.  
 
Study limitations and implications 
We considered recruiting the participants at pediatric clinics as theoretical sampling because 
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adolescent girls mainly receive HPV vaccine at pediatric clinics in Japan. Therefore, study sample 
was limited by those who attend the clinic in the present study, which could give the results an 
unduly large amount of influence. And the response rate of 100% from those who were asked to 
participate in the study is unusual. Our recruitment method, in which physicians distributed leaflets 
and introduced the study to those caregivers who the physicians believed met the inclusion criteria, 
could have influenced those who agreed to participate. Although we had asked the physicians to 
inform the caregivers that their participation in the study was voluntary and that refusal to participate 
would not put them at a disadvantage, it is possible that the participants found it difficult to refuse 
the request of the physicians to participate in the study. This is the first study in Japan that focused 
on HPV vaccination process and influencing factors in adolescent girls. A wider base of adolescents 
perhaps from schools may be the next step where this study needs to go to achieve significant results 
and have power to make conclusions. On the basis of the findings in the present study, we are 
planning to seek enlightenment of children and their families on HPV vaccination. 
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TABLE and FIGURES 
Table 1. Characteristics of the study’s participants 
Figure 1. HPV vaccination process and related factors in adolescent Japanese girls  
Table 1
Characteristics of study participants
Girl's age School Girl's status Family situation
(years) attended by the girl of HPV vaccination
1 17 high school under vaccination (two injections) None
2 14 junior high school completed (all three injections) asthma full amount of the expenses single-female-parent,
three-generation family
3 12 junior high school under vaccination (one injection) asthma, atopic dermatitis 90% of the expenses
4 16 high school completed (all three injections) None
5 14 junior high school under vaccination (one injection) congenital hypothyroidism 90% of the expenses
6 13 junior high school completed (all three injections) 90% of the expenses
7 14 junior high school under vaccination (one injection) . 90% of the expenses
8 14 junior high school completed (all three injections) None
9 16 high school under vaccination (two injections) asthma full amount of the expenses single-female-parent
10 16 high school completed (all three injections) full amount of the expenses three-generation family
11 16 high school under vaccination (two injections) full amount of the expenses
12 17 high school under vaccination (one injection) full amount of the expenses three-generation family
13 14 junior high school under vaccination (two injections) full amount of the expenses three-generation family
14 13 junior high school under vaccination (one injection) full amount of the expenses three-generation family
15 14 junior high school unvaccinated 90% of the expenses
16 17 high school unvaccinated None
17 14 junior high school unvaccinated asthma 90% of the expenses
single-female-parent, on
public assistance
18 17 high school completed (all three injections) None
19 14 junior high school unvaccinated 90% of the expenses
20 16 high school completed (all three injections) 90% of the expenses
Girl's health issueIdentification
no.
Subsidy from the national    and
local government
 
 
［Collect knowledge and 
information on CC and HPV 
vaccine ］①②
［Know experience of 
vaccinated friends and 
vaccination state of  peers ］③
〈First encounter with CC and 
HPV vaccine 〉
［ Parents make an appointment 
with hospital ］⑪
〈 Adjustment with parents 
toward actual vaccination 〉
〈 First thoughts and wavering in attitude 
toward vaccination 〉
〈Discussion with parents 〉
《 Think about and make decision to get HPV vaccine 》
［Arrange the period and schedule 
with parents ］⑩c.
Abbreviations and symbols indicate: 
CC = Cervical Cancer 
IM= Intramuscular
《 》 Core category
〈 〉 Category
［ ］ concept
→ Order of generation
Obstructive factors
a. Financial burden
b. “Voluntary” vaccination
c. Frequent vaccination
Promoting factors 
Figure 1 HPV vaccination process and related factors in adolescent Japanese girls.
Vaccination
［Fear and desire to escape from CC ］④⑤
［Share and discuss the knowledge and information on 
CC and the HPV vaccine with parents ］⑦⑧
［Prioritizing parents’ thinking on HPV vaccination］⑧⑨
［Anxiety regarding IM injection ］
［Priority of qualifying for public financial support  ］⑥a.
［Recognition the value and admiration for HPV vaccine］④⑤
［Tell own thoughts on HPV vaccination to parents］ ⑦
［ Distrust of the HPV vaccine ］b.
①Amount and quality of knowledge and information on CC and HPV vaccine
②Child’s health  literacy on CC and HPV vaccine 
③Peer-pressure
④Fear of CC; Possibility of developing CC ; Awareness of preventing CC
⑤Future self-image and visions
⑥Public financial support system
⑦Parent-child relationship, amount of parent-child conversation
⑧Parental health literacy, parental attitude to health
⑨Reliance on parents, parental influence
⑩Schedule adjustment between the parents and child 
⑪Parental ability to search local resources
 
 
 
